Although the application of RDN isnot clear because of its varying effectiveness, our data suggested that it may be anexcellent choice in obesity-related hypertension patients with high levels of NE andover-activation of the renin-angiotensin system. The gene discussed is REN; the disease is obesity due to melanocortin 4 receptor deficiency.